In the News
Cost Effectiveness of Topical Wound Oxygen Therapy for Chronic Diabetic Foot Ulcers
TWO2® therapy to be included in NHS supply chain framework agreement for 2025
AOTI’s Dr. Mike Griffiths on Breakthrough for Diabetic Foot Ulcers and Chronic Wound Care
AOTI Awarded Five Year Extension To Veterans Administration Contract
AOTI wins the Best Newcomer Award at the AIM Awards 2024
London Stock Exchange welcomes AOTI, Inc. celebrating its successful listing on AIM
AOTI announces US FDA 510(k) Clearance of NEXA NPWT System for use in the home care setting
Treatment Recommendation for Diabetic Foot Ulcers (DFUs) by the Wound Healing Society
AOTI to Present Keynote at Advanced Wound Care Summit Europe
